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SUMMARY 
The anthropogenic pollution of water is becoming a severe problem because of the 
increasing wastewaters generated by the industry and the population day by day. In this 
context, pharmaceuticals are products of special concern. Indeed, pharmaceuticals are used to 
improve the quality of life of humans and animals, but the effect of their accumulation in the 
aquatic system can be dangerous. This study is focused on diclofenac, which is a non-steroidal 
anti-inflammatory drug (NSAID) and is one of the priority substances that, according to the 
European Union, must be monitored in order to determine the risk for the environment. The 
main concern of these pollutants is the persistence in the environment as they are not 
biodegradable and, therefore, they are not completely eliminated by classical wastewater 
treatments.  
Advanced Oxidation Processes (AOPs) are a useful alternative to traditional water 
treatments. To perform the degradation of diclofenac, the most promising AOPs are direct 
photolysis with UV radiation and the combination with hydrogen peroxide. For this reason, in 
this work, the diclofenac was treated with UV/H2O2 and UV photolysis, achieving removals 
higher than 95% with UV/H2O2 and higher than 90% for UV.  Experimental data fit well pseudo-
first-order kinetics. Experiments were also done with only H2O2 and with solar light but the 
percentage of diclofenac removal in both cases was very low. 
Another related problem is the low concentration of these compounds in the superficial 
waters, and for this reason are called micropollutants. Thus, analytical technologies with high 
sensitivity are needed to detect these compounds in the environment and to allow the 
identification of their degradation products. Therefore, liquid chromatography coupled to high-
resolution mass spectrometry (LC-HRMS) has been used, in this work, to identify the 
degradation products. Fourteen intermediates have been detected and degradation pathways 
have been tentatively proposed.  
ii Font i Pomarol, Jana 
Finally, an estimation of the toxicity of the final products of the experiment with the 
computerized predictive system ECOSAR was carried out, because the transformation products 
can be more detrimental than the main product. 
Keywords: Diclofenac, degradation products, Advanced Oxidation Processes, liquid 
chromatography coupled to high-resolution mass spectrometry, toxicity.  
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RESUM 
La contaminació antropogènica de l’aigua esdevé cada cop un problema més greu degut a 
l’augment de les aigües residuals generades per la indústria i la població. En aquest context, 
els productes farmacèutics són compostos especialment preocupants. De fet, els fàrmacs 
s’utilitzen per millorar la qualitat de vida dels éssers humans i dels animals, però l’efecte en el 
sistema aquàtic degut a la seva acumulació, pot ser perjudicial. Aquest estudi es centra en el 
diclofenac, que és un fàrmac antiinflamatori no esteroïdal i és una de les substàncies 
prioritàries que, segons la Unió Europea, ha de ser monitoritzada per determinar-ne el risc per 
al medi ambient. La principal preocupació d’aquests contaminants és la persistència en el medi, 
ja que no són biodegradables i, per tant, no s’eliminen completament després dels tractaments 
clàssics de les aigües residuals.  
Els processos d’oxidació avançada (POAs) són una bona alternativa als tractaments 
d’aigua tradicionals. Per dur a terme la degradació del diclofenac, els POAs més prometedors 
són la fotòlisi directa amb radiació UV i la combinació amb peròxid d'hidrogen. Per aquest 
motiu, en aquest treball s’ha tractat el diclofenac amb UV/H2O2 i amb fotòlisi UV, aconseguint 
una degradació superior al 95% amb UV/H2O2 i superior al 90% amb només UV. Les dades 
experimentals s’ajusten bé a la cinètica de pseudo-primer ordre. També s’han realitzat 
experiments amb només H2O2 i amb radiació solar, però en aquests dos casos pràcticament no 
hi ha hagut degradació. 
Un altre problema relacionat és la baixa concentració d’aquests compostos a les aigües 
superficials, per la qual s’anomenen microcontaminants. Per tant, per detectar aquests 
compostos al medi ambient i permetre la identificació dels seus productes de degradació, es 
necessiten mètodes analítics d'alta sensibilitat. Per això, en aquest treball s'ha utilitzat la 
cromatografia líquida acoblada a l'espectrometria de masses d'alta resolució per identificar els 
productes de degradació. S'han detectat catorze intermedis i s'han proposat possibles vies de 
degradació. 
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Finalment, s’ha fet una estimació de la toxicitat dels productes finals de l’experiment amb el 
sistema predictiu computeritzat ECOSAR, ja que els productes de degradació poden ser més 
perjudicials que el producte principal.  
 
Paraules clau: Diclofenac, productes de degradació, Processos d’Oxidació Avançada, 
cromatografia líquida acoblada a l'espectrometria de masses d'alta resolució, toxicitat.
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1. INTRODUCTION 
Water is essential for life and environment and plays an important role in the economy of the 
planet. Also, it is used in our daily life for alimentation, personal care, and cleaning tasks. Water 
is more than a resource and it must be preserved. The constant growth of the world population 
causes an increase in the demand for potable water while its anthropogenic contamination 
rises. To control this contamination, the European Parliament have been stablished the Water 
Framework Directive (WFD) 2000/60/EC. 
There is a rising concern about the occurrence and persistence of emergent contaminants 
that come mostly from industrial activities and pharmaceutical and personal care products. 
Although these contaminants are often named ‘‘emerging’’, most of them have been present in 
the environment for many years but were not detected before due to the lack of proper and 
highly sensitive instruments. The development of the analytical methods such as electrospray 
ionisation mass spectrometry (ESI-MS) in the 1980s and the improvement in sensitivity of mass 
spectrometers are what have allowed to identify and measure these contaminants [1]. 
Pharmaceuticals are greatly used in modern life and their benefits for human and animal 
health, are widely known, but the adverse side effects that they can produce in the natural 
environment have not been enough studied. Although these contaminants are found in low 
concentrations, they can be damaging for aquatic organisms and for human health if they 
accumulate in the environment, the food chain or get into drinking water. For example, 
diclofenac is one of the pharmaceuticals used every day for millions of people in Europe.  
Moreover, many of these contaminants can suffer a transformation in our organism by 
metabolization, and in the environment due to processes as microbial degradation, photolysis, 
and hydrolysis, and they can also react with disinfectants in drinking water or wastewaters to 
form disinfection subproducts [1]. Often, these transformation products are quite stable in the 
environment, but sometimes can be more toxic than the parent compounds. 
The issues with these emerging contaminants are basically due to their bioaccumulation, 
persistence, and toxicity. They are not biodegradable and therefore the traditional water 
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treatment plants are not able to achieve the complete removal of them. However, Advanced 
Oxidation Processes (AOPs) are a useful alternative to these treatments. 
 DICLOFENAC 
Is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and 
inflammatory diseases such as gout, osteoarthritis or rheumatoid arthritis. It reduces swelling 
and stiffness in the joints, muscles and bones. Diclofenac comes as tablets, capsules and 
suppositories.  
Like all medicines, diclofenac can cause side effects. The most common are abdominal 
pain, gastrointestinal bleeding, dizziness, nausea, swelling and headache. 
Diclofenac was patented in 1965 and was started to use as a medicine in the United States 
in 1988. [2] 
The presence of diclofenac in the aquatic environment has been described in different 
studies. For example, concentrations up to the µg/L have been found in surface water samples 
collected from canals and rivers in Berlin [3]. In the Baltic Sea region 54 ng/L of diclofenac have 
been measured as a maximum concentration in water samples [4]. Also, in the Llobregat River 
this compound exceeded 10 µg/L [5].  
 LEGAL FRAMEWORK  
The Water Framework Directive 2000/60/EC recognize “water not as a commercial product 
like any other but, rather, a heritage which must be protected, defended and treated as such” 
[6]. The purpose of the directive is to achieve a good ecological and chemical quality of ground 
and surface waters. For that, it is important to prevent pollution, promote sustainable use, 
protect its environment, improve the state of ecosystems and relieve the effects of floods and 
drought episodes. 
A surface water Watch List (WL) mechanism of the Water Framework Directive (WFD) was 
stablished in 2008 under the Priority Substances Directive 2008/105/EC (as amended by 
directive 2013/39/EU). The aim of this mechanism is to collect high-quality monitoring data to 
determine if the chemicals selected represent a significant risk to the river basins of the 
European Union [7].  
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This Watch List is thought to be regularly updated in order to better inform the determination 
of adequate measures to minimize the risk. 
Diclofenac appears on the Watch List of pharmaceuticals described on the directive 
2013/39/EU as a priority substance, and an annual average environmental quality standard 
(EQS) of 10 ng/L has been proposed for it [4]. The EQS is a maximum acceptable concentration 
limit of a substance in a body of water, necessary to maintain the quality of the environment. 
 ADVANCED OXIDATION PROCESSES  
The anthropogenic pollutants are hardly eliminated by the microorganisms in biological 
treatment of wastewater produced in the industry, therefore there is an important necessity to 
study new technologies such as advanced oxidation processes. These treatments are used to 
complement the conventional physicochemical and biological treatments and accomplish the 
day-to-day more exigent limits fixed by environmental regulations [8]. 
AOPs use the powerful hydroxyl (OH·) radical as a major oxidizing agent. The hydroxyl 
radical has a high oxidation potential (Eº=2.80V). Its non-selective behaviour allows to attack 
almost any organic compound and is useful to degrade contaminants at very low concentration.  
 The generation of these radicals can be achieved from different chemical reactions. 
Depending on whether there is radiation or not, AOPs can be classified as photochemical 
processes or non-photochemical processes. 
 
Table 1. AOPs classification. (Litter & Quici, 2010) [9] 
 
 
 
 
 
Photochemical Non-photochemical 
UV/O3  
UV/H2O2 Ozonation at alkaline pH (>8.5) 
O3/UV/H2O2 Ozone +catalyst 
Photo-Fenton Fenton 
UV/TiO2 Non-thermal plasma 
Photolysis Ultrasonic cavitation 
UV/H2O2/TiO2  
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1.3.1. Photolysis combined with Hydrogen Peroxide (H2O2) 
Ultraviolet (UV) light irradiation is widely used for disinfection of drinking water and is a 
promising process for wastewater purification. 
The combination of UV with H2O2 can improve the removal of pharmaceuticals compared to 
UV alone. The hydroxyl radical is produced during the process as a result of photolysis of the 
peroxide. It is a strong oxidant and can attack a wide range of organic compounds causing 
degradation through hydroxylation and dehydrogenation. 
Photodegradation reactions can occur directly and indirectly. In direct photodegradation, a 
compound absorbing radiation can become unstable and consequently decay, whereas the 
indirect way involves compounds that produce strong reactive species (such as hydroxyl 
radicals) that then react with organic compounds [10].  
UVC monochromatic lamps emitting at 254 nm can provide enough energy to break a wide 
range of organic bonds. This cleavage is possible when the photonic energy absorbed by the 
compound surpass the bond energy. For example, UVC can break a carbon-chlorine bond of a 
chlorinated compound like diclofenac and lead to the formation of chlorine radical [11]. Also, at 
this wavelength, hydrogen peroxide has a high molar extinction coefficient so that a part of 
photons emitted by the lamp is used in its photolysis and therefore two hydroxyl radicals are 
created [12].   
H2O2 + hv (254 nm) → 2HO• (Eq.1) 
 ANALYTHICAL METHODS  
The improvement in analytical methods is a great step in the detection of emerging 
contaminants. They allow to establish the presence of these chemicals in the environment, to 
estimate their concentration levels and to determine their degradation pathways. 
In the environmental analysis, it is required a highly selective and wide range of analytical 
methods, because of the complexity of the matrices of water samples, and the large number of 
organic contaminants present in these samples. The low concentrations at which these 
pollutants are found in the environment and their different physicochemical properties demand 
high detection sensitivity. In addition, structural information is needed for the characterization of 
the main parent compound and its degradation products. Most of the studies are focused only 
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on the identification and degradation of the contaminant but sometimes the intermediates can 
be more persistent and toxic than the original. That's why it requires a thorough study [13] [14]. 
Due to the continuous contamination of water, an improvement in technology is required to 
provide sensitive, selective and specific methods able to obtain a rigorous identification, 
confirmation and quantification of these compounds. This breakthrough is possible as a result of 
the combination of high-resolution mass spectrometry (HRMS) and liquid chromatography (LC). 
While liquid chromatography provides the separation of multiple components, mass 
spectrometry allows to identify the structure of the individual components with high molecular 
specificity and detection sensitivity.  
Liquid chromatography is a separation technique based on the interaction of the samples 
with the stationary and mobile phases and it is especially satisfying for the separation of low 
volatility polar compounds such as diclofenac. 
The high-resolution mass spectrometers, such as TOF and Orbitrap, represent a promising 
option to identify non-targeted compounds in real samples. Its main characteristics are the high 
resolving power, the mass accuracy measurement and the high full-scan sensitivity. 
The resolving power allows to detect two compounds with the same nominal but different 
exact mass. There is some controversy when it comes to defining this concept. According to the 
IUPAC, the resolving power (Δm) is the ability to discern between ions differing in the quotient 
mass/charge (m/z) by a small increment [15]. While the resolution is defined as m/Δm, where m 
is the nominal mass of the interest molecule and Δm is the width of the peak at fifty percent of 
the maximum peak height, sometimes named Full Width of the peak at Half its Maximum 
(FWHM). 
The mass accuracy (eq.2) is evaluated in ppm units of error, and depends on diverse 
factors such as ionisation source, peak shape and calibration.  
ppm =
Theoretical mass − Experimental mass
Theoretical mass
· 106 
(Eq.2) 
In full-scan mode, the mass spectrum is continually acquired between two different m/z ratio 
in a certain period of time (mostly ≤1 s), and all the compounds between this ratio can be 
detected [16]. 
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2. OBJECTIVES 
The main objectives of this project are the degradation of diclofenac using Advanced 
Oxidation Processes (UV/H2O2 and UV photolysis) and the identification of the transformation 
products by liquid chromatography coupled to high-resolution mass spectrometry. 
As specific objectives, kinetics will be studied and, with identified degradation products, 
possible reaction pathways will be proposed. 
Finally, the toxicity of the final samples will be estimated to be able to determine if the 
subproducts formed are more detrimental than the main compound. 
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3. MATERIALS AND METHODS 
 REAGENTS 
Diclofenac sodium salt, from Sigma-Aldrich, was the pharmaceutical used to carry out the 
research.  
Table 2. Diclofenac properties [17]. 
Names and Identifiers 
IUPAC name 2-[2-(2,6-dichloranilino) phenyl]acetic acid 
CAS Number 15307-86-5 
Molecular formula C14H11Cl2NO2 
Molecular structure 
 
Chemical and physical properties 
Property Value 
Monoisotopic Mass [g/mol] 295.02 
Solubility (at 25ºC) [mg/L] 2.37 
pka 4.15 
Melting point [ºC] 283-285 
log Kow 4.51 
The following table shows the other reagents employed for the experiments. 
Table 3. Information about the other reagents [17]. 
Name CAS No. Formula Company Purity [%] Used in/for 
Hydrogen peroxide 7722-84-1 H2O2 Merck 30 w/v UV/H2O2 
Acetonitrile 75-05-8 CH3CN LiChrosolv 99.9 LC-HRMS 
Methanol 65-56-1 CH3OH SupraSolv - LC-HRMS/ SPE 
Formic acid 64-18-6 HCOOH EMSURE 98-100 LC-HRMS 
Water 7732-18-5 H2O SupraSolv - LC-HRMS/ SPE 
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 WATER MATRIX 
For all experiments, it was used bottled commercial water of glass. 
Table 4. Characteristics of water. 
 
 
 
 
 
 
 
This water has been selected as a blank of water matrix without the presence of pollutants. 
Also, its organic composition was previously characterised by the laboratory. 
 EXTRACTION METHOD 
For some experiments, solid phase extraction (SPE) in reversed phase was employed to 
clean up the samples and pre-concentrate it prior to analysis. In this extraction process, the 
analyte of interest is retained in the stationary phase (sorbent) of the cartridge and then is eluted 
by an adequate solvent. 
It was used an Oasis HLB cartridge, with a capacity of 6mL and 200 mg of sorbent, as its 
name suggests, it is a hydrophilic-lipophilic balance polymer, that remains wetted with water and 
can retain a wide spectrum of both polar and nonpolar compounds.  
The sensitivity of the analysis of the degradation products rises doing the extraction. 
 ANALYTHICAL METHODS 
3.4.1. LC-HRMS 
The analysis of the samples was done by LC-HRMS in an Orbitrap mass spectrometer 
using electrospray ionisation.  
Composition [mg/L] 
Dry waste 203.0 
Calcium 71.3 
Sodium 0.8 
Magnesium 1.9 
Bicarbonates 198.0 
Sulphates 15.7 
Chlorides 1.9 
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The Orbitrap is a mass analyser composed of two outer electrodes and a central one (figure 
1). Ions generated, by using an ion source, enter to the device and then are radially trapped 
around the central electrode, where after they oscillate. Finally, measuring the different 
oscillation frequencies (depending on the mass/charge ratio of the ions), the mass spectra of 
the ions are acquired using image current detection [14]. 
 
Figure 1. Orbitrap diagram. 
The chromatographic separation was performed on a reversed phase Phenomenex Luna 
C18(2) column (150 mm x 2.0 mm, 5 µm) using as a mobile phase 0.1% of formic acid in water 
as a solvent A and 0.1% of formic acid in acetonitrile as a solvent B at a constant flow rate of 
200 µL/min. The gradient started with 5% of B and increase to 90 % of B for 15 min and then, 
after 9 min, returned to initial conditions for re-equilibrate (5% of B). The total duration of the 
method was 34 min. The injection volume was 5 µL for the samples. 
Mass spectrometry data were acquired in both positive and negative ionisation and in full-
scan mode from 50 to 1000 m/z, with a resolution of 50,000 (at 200 m/z; 2 Hz). Also, an 
injection time of 250 ms and Automatic Gain Control (AGC) of 1x106 were used. 
3.4.2. Total Organic Carbon 
Total organic carbon (TOC) is the total amount of carbon present in organic compounds and 
it is used as a parameter to assess the quality of the aqueous systems.   
To analyse the TOC, it has used a Shimadzu 5055 TOC-VCSN analyser with an ASI-V 
Autosampler following the 5220D-standard method. 
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 EXPERIMENTAL DEVICE 
The AOPs experiments were done in a 2 L jacketed batch reactor made of Pyrex (figure 2), 
with a continuously cooling current at 25 ºC. It was 23 cm high and 11 cm of inside diameter. 
Three monochromatic UVC lamps (Philips TUV 8 W, G8T5) with a wavelength of 254 nm were 
located in the axis of the reactor and a magnetic stirrer was used to provide a uniform mixture of 
the solutions during the experiment.  
Figure 2. Schematic diagram of 2 L batch reactor: (1) reactor, (2) lamp, (3) stirrer, (4) 
cooling water input, (5) cooling water output, (6) sampling gap. 
 
For one experiment was utilized a solarbox XENOTERM-1500RP, with a UV lamp (≈290- 
2000 nm) that simulates the solar radiation spectrum. In this case the photoreactor was 24.5 cm 
length and 2 cm of diameter and is connected to a supply tank. The recirculation rate is large 
enough and the reactor volume is small enough to be able to consider the same concentration 
in all the system in a specific moment. Figure 3 shows a schematic diagram. 
After the degradation experiments, a SPE of the samples was done. The cartridges of the 
extraction were placed in a cube connected to a vacuum pump and to load the samples an 
adapter of 60 mL was put, as it can be seen in the figure 4. After this, the samples were 
concentrated at 500 µL using a nitrogen flowrate of 40ºC by TurboVap Cassic II with sensor 
endpoint detection and a maximum sample volume of 200 mL. To finish to concentrate at 250 
µL was used a Pasvial. 
(1) (6) 
(2) 
(4)
) 
(5) 
(3) 
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Figure 3. Schematic diagram of solarbox: (1) tank, (2) photoreactor, (3) stirrer, (4) cooling 
water input, (5) cooling water output, (6) sampling gap, (7) solarbox, (8) recirculation. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Schematic diagram of SPE: (1) adapters, (2) cartridges, (3) valves, (4) vacuum 
pump, (5) cube. 
 
 
(1) 
(2) 
(3) 
(5) 
(4) 
(6) 
(7) (8) 
(1) 
(2) (4) 
(3) 
(5) 
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 EXPERIMENTAL PROCEDURE 
The diclofenac degradation was carried out during one hour using distinct concentrations of 
peroxide and types of light in several experiments shown in table 5. 
Table 5. Completed experiments. 
Experiment H2O2 [mg/L] Light 
UV/H2O2 20 UVC 
UV/H2O2 20 UVC 
UV/H2O2 50 UVC 
UV - UVC 
H2O2 50 - 
Solarbox 50 Sunlight simulator 
 
Steps followed for the realization of the experiments: 
1. Preparation of the solution of diclofenac with mineral water. Weigh 100 mg of the 
pharmaceutical and dissolve in a 2 L volumetric flask. 
2. Agitation to dissolve the contaminant properly for about 15 or 20 minutes. 
3. Activation of the thermostatic bath to reach 25ºC and switch on the light to 
tempered it. 
4. Introduction of the solution into the reactor with a stirring of 300 rpm and with the 
lamp off. 
5. At zero time the first sample was taken before introducing the H2O2 with the 
solution. 
6. Injection of the H2O2, at the same time, switch on the light and then the 
experiment begins. 
7. 20 mL of sample were taken at minutes 0, 0.5, 2, 4, 5, 10, 20, 30, 45 and 60. At 
zero time and at the end of the experiment, 15 mL were also extracted for the 
TOC. 
8. Disconnection of thermostatic bath turn off the light and stop the agitation. 
One aliquot of 1 mL of the sample was reserved for the analysis by direct injection in the 
Orbitrap and the remaining was treated with SPE in order to pre-concentrated. 
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To conduct the extraction, the cartridges were first conditioned and equilibrate with 5 mL of 
MeOH and then 5 mL of water. The samples (≈20 mL) were loaded at a flow rate of 3-5 mL/min 
retaining the compost of interest into the cartridge, then 5 mL of water to eliminate interferences 
soluble on it. The diclofenac and the extracted degradation products were eluted with 5 mL of 
MeOH two times at a flow rate of 1-2 mL/min. 
Extraction method diagram: 
Condition/Equilibrate: 
(5mL MeOH/5mL H2O) 
 
Load the Sample: 
(20mL) 
 
Wash: 
(5mL H2O) 
 
Elution: 
5mL MeOH (x2) 
 
Before the analysis, the elution was concentrated at 250 µL and then was reconstituted with 
water until 1 mL to get an adequate proportion of MeOH/H2O2. Considering that the mobile 
phase of the LC starts with a proportion of aqueous phase of 95% regarding to organic phase, 
the more similar the proportion of the sample at the initial mobile phase, the better is to obtain a 
more defined peak. 
Finally, the samples were stored at 6ºC in amber vials of 1 mL until the LC-HRMS analysis. 
 IDENTIFICATION PROCEDURE 
A bibliographical search of the possible degradation products of diclofenac under different 
AOPs was done in order to make a database with the exact mass of both positive and negative 
ions from the molecular formulas of these degradation products. The ion exact mass were 
calculated using Xcalibur software. 
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After that, the following ruler based on accurate mass measurements was used to identify 
and describe the degradation of products. First, a visual inspection of the TIC (total ion current) 
chromatogram was done to detect the most intense peaks and then the mass spectrum of each 
chromatographic peak, which shows the experimental m/z, was evaluated. 
For each m/z, the software generates various molecular formulas by delimiting the elements 
and the number of them based on the molecular formula of diclofenac and considering the 
degradation process by oxidation, therefore C, H, N, O, and Cl were the elements considered in 
the present study. Then the most adequate formula was selected taking into account: 
• The Ring Double Bond (RDB) equivalent value, which provides us the information 
about how many unsaturations the molecule has. 
• The mass error, which has to be less than 5 ppm. 
• The isotopic pattern has to be compared with the theoretical.  
• The bibliography: Validate if the metabolites are described by other authors. 
Once the molecular formula of the signal was confirmed, it was verified that the retention 
time (tR) was maintained in the different samples of the same experiment. It cannot vary more 
than 2.5%. Also, the isotopic pattern, the mass accuracy and the RDB of each sample were 
checked. 
All this procedure was done for each peak detected in TIC both in positive and negative 
ionisation mode. Low abundance compounds maybe are not apparent visual peaks at first 
inspection, and intense peaks do not necessarily have to be associated with a single component 
or with organic contaminants of interest. 
Additionally, to describe the structural formula of the degradation products, the bibliography 
was checked. If the molecular formula was not defined there, the structural formula could be 
established from the difference in mass with diclofenac and considering diverse possible 
mechanism of degradation, such as the loss of chlorine or group acid, the gain of hydroxyls or 
oxygen and dimerization.  
Finally, the areas of the peaks of each sample were compiled to evaluate the evolution of 
the compound during the experiment and to graph it. 
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4. RESULTS AND DISCUSSION 
Table 6 shows all the experiments done using distinct concentrations of hydrogen peroxide 
and types of light.  It shows also the percentage of organic carbon mineralized and the 
percentage of diclofenac degradation. 
 
Table 6. Percentage of diclofenac removal in the different experiments carried out and TOC 
analysis. 
Experiments H2O2 [mg/L] Light TOC [%] 
Degradation [%] 
(SPE) 
Degradation [%] 
(direct injection) 
UV/H2O2 20 UVC 10.6 90.5 97.3 
UV/H2O2 20 UVC 8.1 - 96.1 
UV/H2O2 50 UVC 8.3 91.1 97.0 
UV - UVC 9.8 81.4 91.8 
H2O2 50 - 1.3 - 2.0 
Solarbox 50 
Sunlight 
simulator 
0.6 - 0.8 
 
In the first four experiments, TOC degradation is really low. However, diclofenac removal 
can achieve high percentages. In the experiment carried out only with H2O2, there is practically 
no degradation of TOC or diclofenac. The same can be said for the experiment done in a solar 
simulator with a lamp emitting radiation close to the solar one, which no degradation of TOC or 
diclofenac were observed due to the particular wavelength range of the used light, as it will be 
commented below. 
The SPE has been employed to clean up the samples and concentrate them before the 
analysis. So, it is obtained a better response in the analysis of the degradation products. 
 DEGRADATION OF DICLOFENAC 
Figure 5 correspond to all degradation processes carried out. As it can be observed, there is 
no degradation in the experiments done with a solar simulator or with only hydrogen peroxide 
without any type of light. Whereas with UV photolysis and UV/H2O2 there is practically a total 
degradation. The hydrogen peroxide itself does not affect diclofenac. However, H2O2 combined 
with UVC increase lightly the diclofenac removal, due to the ability of the hydroxyl radicals 
generated to attack organic compounds. The points of the figure show the experimental data 
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while the tiny discontinuous lines are drawn to be able to appreciate better the trend of the 
results. 
Figure 5. Degradation of diclofenac by different AOPs. Initial concentration of 50 ppm of 
diclofenac. Data from direct injection by LC-HRMS. 
 
Diclofenac has a maximum absorption at 276 nm [11], but in the range of wavelengths of 
solar radiation, the part corresponding to 300 nm is small in comparison with all radiation (see 
figure 6). Therefore, the solar radiation is not able to directly degrade diclofenac and nor to 
generate hydroxyl radicals from hydrogen peroxide. Consequently, one hour of experimentation 
in the solarbox, with 50 ppm of hydrogen peroxide, produces no degradation of diclofenac. 
As figure 5 shows, diclofenac is easily photodegradable by UV photolysis and the 
combination of UV/H2O2 does not mean a significant improvement. With just UV radiation, 92% 
of degradation was obtained and adding H2O2 it increases only 5%. According to other authors, 
there is no difference in increasing the hydrogen peroxide concentration [10] [18] [19] [20]. 
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Figure 6. Solar radiation spectrum [21] 
 
So, the hydroxyl groups formed practically do not step in the degradation of the compound. 
This might be due to the fact that the action of photolysis is faster than hydroxyls or the main 
target of these hydroxyls is another compound present in the sample. In any case, the 
predominant degradation mechanism in the experiments was the photolysis. 
In this experiment, mineral water with a concentration of 198 mg/L of bicarbonate has been 
used. This bicarbonate has a reaction rate constant with hydroxyl radicals of 8.5x106 L/(mol·s) 
[22], whereas the reaction rate constant of diclofenac is 1.36x1010 L/(mol·s) [19]. Diclofenac 
clearly has a higher constant, but considering that there is almost four times more bicarbonate 
than diclofenac, it could be possible that bicarbonate will be degraded by the hydroxyls before. 
 KINETICS OF DEGRADATION 
The degradation reaction was fitted to a pseudo-first-order kinetics using the following 
equation: 
𝐶 = 𝐶𝑜 · 𝑒𝑥𝑝 (−𝑘𝑡) (Eq.3) 
Linearizing the equation, it remains in the form: 
Where k is the pseudo-first-order rate constant for direct or indirect photolysis, Co is the 
initial concentration of diclofenac, C the concentration at any time and t is the experimental time. 
 
𝑙𝑛 (
𝐶
𝐶0
) = −𝑘 ∙ 𝑡 (Eq.4) 
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Thus, fitting the data of figure 5 to this equation drives to figure 7.  
Figure 7. Kinetics linearization for the degradation experiments. Experimental values are 
shown with dots and the fitted values with the straight lines. 
 
Figure 7 shows more clearly how the experiments with UV/H2O2 achieve higher degradation 
than UV photolysis, and it can be verified in table 7, where the kinetic constants obtained from 
linearization are shown. Effectively, the kinetic constants obtained when H2O2 was used are, as 
minimum as 20% higher than the kinetic constant obtained using only UV light, without H2O2. 
This fact corroborates what has already been said before about the fact that photolysis has a 
much more preponderant role in the diclofenac removal than hydroxyl radicals. In both cases, 
from figure 7 and table 7, it can be said that data fit well pseudo-first-order kinetics.  
 
Table 7. Kinetic constants. 
Experiments k [min-1] R2 
(1) UV/H2O2 (20 ppm) 0.058 0.998 
(2) UV/H2O2 (20 ppm) 0.053 0.998 
UV/H2O2 (50 ppm) 0.056 0.996 
UV 0.042 0.994 
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 FORMATION OF DEGRADATION PRODUCTS 
 The degradation products were analysed in three different experiments: UV/H2O2 with 20 
ppm and 50 ppm of hydrogen peroxide and UV photolysis. 
The three graphs below (figures 8, 9 and 10) show the degradation of the diclofenac and the 
formation of its major transformation products.  It can clearly be seen the formation of a main 
product (D1). Comparing the graphs, a higher degradation of D1 and the formation of more 
subproducts and more intense was observed with UV/H2O2 regarding to the UV photolysis. This 
can be due to D1 might be more affine to be degraded by hydroxyls than diclofenac. 
These figures show the transformation products appearing after the D1, because probably 
they are formed from it. From the shape of the curves and from the time at which appeared the 
different intermediates, it seems clear that D1 comes from the direct degradation of diclofenac, 
because it appears when experiment just started. The other compounds appear later and can 
be the result of the degradation of D1 or diclofenac. All this will be discussed widely when the 
possible reaction pathways will be commented below. 
Figure 8. Evolution of main degradation products formed during degradation of diclofenac 
(50 ppm) by UV with 50 ppm of hydrogen peroxide. 
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Figure 8 and 9 are practically the same, therefore there is no difference in the degradation 
or the generation of subproducts when the H2O2 concentration is increased.  
Figure 9. Evolution of main degradation products formed during degradation of diclofenac 
(50 ppm) by UV with 20 ppm of hydrogen peroxide. 
Figure 10. Evolution of main photolytic degradation products formed during degradation of 
diclofenac (50 ppm) by UV. 
0
20
40
60
80
100
0 10 20 30 40 50 60
C
/C
o
time (min)
UV
Diclofenac
D1
D2
D4
D5
0
20
40
60
80
100
0 10 20 30 40 50 60
C
/C
o
time (min)
UV/H2O2 (20ppm)
Diclofenac
D1
D2
D3
D4
D5
D6
Degradation of diclofenac using AOPs and identification of its degradation products by LC-HRMS. 23 
 
Figure 10, when only UV is used without H2O2, shows, as indicated above, a slowdown in 
the degradation of intermediate D1, which is also related to the lower amounts observed of the 
other transformation products. 
 IDENTIFICATION OF DICLOFENAC AND ITS DEGRADATION 
PRODUCTS 
4.4.1. Diclofenac 
In order to identify the diclofenac and its degradation products, the ruler based on the 
accurate mass measurements explained before has been followed. In figure 11, the 
experimental pattern isotopic of diclofenac in a specific sample, coincides with the theoretical as 
well as the RDB, and the mass accuracy is less than 5 ppm. 
 
Molecular Formula [M-H]- Experimental m/z [M-H]- Error ppm RDB 
 
C14H10Cl2NO2 294.0098 1.2 9.5 
 
(A) Experimental 
(B) Theoretical 
Figure 11. (A) Experimental LC-HRMS mass spectrum of diclofenac in the sample of 10 min 
of experimentation by UV/H2O2 (20ppm) and (B) theoretical mass spectrum of diclofenac 
simulated by Xcalibur software. 
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Diclofenac has a characteristic structure. The presence of two chlorines provides a 
characteristic pattern isotopic. The amino group and the acid group, that form it, allow to detect 
the compound at both positive and negative scan mode. The first group is more likely to be seen 
in positive and the second one in negative.   
At figure 11, it is possible to see the characteristic pattern isotopic of chlorine which helps to 
identify diclofenac and the subproducts. The spectrum shows the molecular ion peaks M, M+2, 
and M+4 which appear due to the various combinations of chlorine isotopes that are possible. 
Each one represents, respectively, the possibility to have two 35Cl, one 35Cl and one 37Cl, and 
two 37Cl. The separation between them is of 2 m/z units and with peak heights in the ratio of 
9:6:1. 
If the compound has only one chlorine atom, the spectrum has to show the peaks of 
molecular ions M, M+2 with a ratio of 3:1 in the peak heights. It is a good way to know if the 
compound has one or two chlorines just by looking at the spectrum. 
Diclofenac and most of its transformation products were detected in both positive and 
negative ionisation, but in practically all of them we get a more sensitive signal in negative. 
During the analysis by LC-HRMS, they have been fragmented due to the high voltage at the 
ionisation source. Therefore, two signals appear at the spectrum for each chromatographic 
peak.  
As it can be observed in figure 12, we have one signal for diclofenac and the other for the 
fragment. The difference between both shows the loss of the acid group. At the qualitative 
representation of the results, the fragments were not considered because the ratio between the 
fragment and the compound remained during all the experiments. 
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Figure 12. LC-HRMS mass spectrum of diclofenac and its fragmentation in the sample of 10 
min of experimentation by UV/H2O2 (20ppm). 
4.4.2. Degradation products 
In the degradation of diclofenac, fourteen different degradation products have been 
identified and described, and some of them have been reported for the first time. 
Diclofenac transformation products were eluted through the chromatographic column at 
different retention times based on their polarity. All of them appeared at a lower tR than 
diclofenac as shown in figure 13, suggesting that they are more polar. 
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Figure 13. LC-HRMS chromatogram of the experiment with UV/H2O2 (50 ppm). Evolution of 
diclofenac and its degradation products. 
 
The previous chromatogram shows the evolution of the diclofenac and the degradation 
products during an experiment. It is possible to see the increasing trend of D1 during just the 
first 10 minutes, whereas the others increase progressively and diclofenac decrease until the 
end.  
Hereunder, from all the identified compounds, the most significant in the experiments 
performed with UV/H2O2 has been described below in table 8, that is, those with a major peak 
abundance.  
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Table 8. Diclofenac degradation products produced under UV/H2O2 and identified by LC-HRMS. 
Peak 
abundance 1 
Neutral Structural Formula ESI 
Molecular 
Formula 
[M-H]- /[M+H]+  
Experimental 
m/z 
[M-H]- /[M+H]+  
Error 
ppm 
RDB tR  
Diclofenac  
100% 
 
 
NEG C14H10Cl2NO2 294.0098 1.2 9.5 15.1 
D1   70% 
 
 
NEG C14H9ClNO2 258.0330 1.2 10.5 14.2 
D2   12% 
 
 
NEG C14H10NO3 240.0669 1.3 10.5 11.5 
D3   7% 
 
 
NEG C14H10Cl2NO3 310.0048 1.4 9.5 12.7 
D4   3% 
 
 
NEG C14H10NO2 224.0721 1.7 10.5 12.9 
D5   3% 
 
POS C28H21N2O6 481.1396 0.4 19.5 12.0 
D6   3% 
 
 
NEG C14H8N05 270.0412 1.5 11.5 10.3 
 
(1) Relative abundance regarding diclofenac initial amount. 
The data included in this table refers to results from sample of 10 min of experimentation.   
The structure of D5 and D6 has been tentatively assigned according to similar formulas found in the bibliography. 
NEG: negative ESI, [M-H]- 
POS: positive ESI, [M+H]+ 
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The next table (table 9) shows the transformation products identified in the experiment with 
UV photolysis. As it can be observed, the subproducts described are the same as the other 
experiments, but with less abundance and without the presence of D3 and D6 that are formed 
by the presence of H2O2. 
Table 9. Diclofenac degradation products produced under UV photolysis treatment and 
identified by LC-HRMS. 
Peak  
abundance 1 
Neutral Structural Formula ESI  
Molecular 
Formula 
[M-H]- /[M+H]+  
Experimental 
m/z 
[M-H]- /[M+H]+  
Error 
ppm 
RDB tR 
Diclofenac 
100% 
 
NEG C14H10Cl2NO2 294.0090 -1.4 9.5 15.1 
D1   70% 
 
NEG C14H9ClNO2 258.0323 -1.8 10.5 14.1 
D2   8% 
 
NEG C14H10NO3 240.0662 -1.9 10.5 11.5 
D5   5% 
 
POS C28H21N2O6 481.1392 -0.5 19.5 12.0 
D4   3% 
 
NEG C14H10NO2 224.0714 -1.2 10.5 12.9 
 
(1) Relative abundance regarding diclofenac initial amount. 
The data included in this table refers to results from sample of 10 min of experimentation.   
The structure of D5 has been tentatively assigned according to similar formulas found in the bibliography. 
NEG: negative ESI, [M-H]- 
POS: positive ESI, [M+H]+ 
 
 
Degradation of diclofenac using AOPs and identification of its degradation products by LC-HRMS. 29 
 
With the identified and described compounds, an attempt has been made to trace a possible 
pathway of degradation. 
Figure 14. Tentative degradation pathway for diclofenac under UV/H2O2 treatment. Within the 
rectangle: direct photolytic degradation products.  
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As figure 14 shows, the UV light leads to sequential elimination of the chlorine substituents 
of diclofenac structure, followed by ring closure to form carbazole-1-acetic acid (D4), which is 
considered as the elemental photolytic degradation product [10] . 
With the loss of the first chlorine, it is formed the most abundant product, D1, which reached 
its highest concentration after 10 min of exposure and represents 70% of the initial 50 mg/L of 
diclofenac. The second product of direct photolysis, D2, is formed by the substitution of the 
chlorine atom from D1 with the hydroxyl group, the product can be considered as a stable.  
Also, a dimer formation, such as D5, has been detected during the experiment, which could be 
formed by coupling two molecules of D2. The mechanism of dimer formation has previously 
been studied [11]. The authors report that singlet oxygen formed during the experiment can 
participate in reactions with unsaturated bonds and probably improve the formation of radicals 
that result in dimerization. 
In this current analysis, two products have been identified resulting from radical 
transformation in the presence of hydrogen peroxide, i.e., product D3 and D6. D3 had a similar 
trend as D1, after 10 min both dramatically decrease which could indicate that this degradation 
product was also produced directly from diclofenac whereas D6 might be formed from the gain 
of one oxygen and one hydroxyl of D2. 
Other products have been identified, but with an intensity less than 2% of the initial amount 
of diclofenac, so they have not been included in the degradation pathway, their data are 
described at table 10. Signals under 1% have been discarded. 
In some cases, two or three different molecules can be associated with the same m/z, which 
could be attributed to isomeric compounds. D7, D8 and D9 are isomeric structures differing in 
the position of the hydroxyl group and the chlorine. Also, D11 can be an isomer of D3, but the 
first one is found in less abundance than the second one, suggesting that one structure is more 
probable. 
With current methods, it is possible to determine the elements forming a molecule but it is 
not possible to define the exact position of each element.  
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Table 10. Other diclofenac degradation products produced under UV photolysis or UV/H2O2 
treatments identified by LC-HRMS with a peak abundance regarding diclofenac lower than 2%. 
Treatments 
 Neutral Structural 
Formula 
ESI 
Molecular 
Formula 
[M-H]- /[M+H]+  
Experimental 
m/z 
[M-H]- /[M+H]+  
Error 
ppm 
RDB tR  Name 
UV/H2O2 
and UV 
 
NEG 
C14H11ClNO3 
276.0432 -0.4 9.5 11.3 D7 
NEG 276.0437 1.4 9.5 11.9 D8 
NEG 276.0436 1.1 9.5 13.0 D9 
UV/H2O2 
and UV 
 
POS C14H10Cl2NO3 310.0035 -2.6 9.5 12.6 D10 
UV  
 
NEG C14H10Cl2NO3 310.0047 1.2 9.5 13.8 D11 
UV 
 
NEG C14H8NO4 254.0457 -0.6 11.5 10.4 D12 
UV/H2O2  - NEG C28H17N2O8 509.1000 2.0 21.5 11.4 D13 
UV/H2O2 
 
NEG C14H9ClNO5 306.0179 1.4 10.5 11.4 D14 
 
The data included in this table refers to results from sample of 30 min of experimentation.   
The structure of D14 has been tentatively assigned according to similar formulas found in the bibliography. 
It was no possible to propose a reliable structure for D13. 
NEG: negative ESI, [M-H]- 
POS: positive ESI, [M+H]+ 
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 TOXICITY 
Finally, the aquatic toxicity of the major identified transformation products has been 
estimated using ECOSAR (Ecological Structure Activity Relationships), which is a computerized 
predictive system that predicts the potential toxicity of industrial chemicals to aquatic organisms. 
It is developed by EPA (United States Environmental Protection Agency). The program contains 
a library of measured data of Quantitative Structure Activity Relationships (QSARs) based on 
the chemical class to predict the toxicity. QSARs provides acute (short-term) and chronic (long-
term) toxicity values in mg/L for fish, aquatic invertebrates (Daphnia), and aquatic plants (green 
algae), which are species that represent the aquatic food net [23]. 
In this study the values used were lethal concentrations (LC50) that is the concentration 
of a substance required to kill half of the population of study after a specific duration. 
Figure 15 shows lethal concentrations by different organisms. So, the higher the 
concentration, the less toxic the compound, because it is needed a larger concentration to kill 
half of the population. 
Figure 15. Toxicity of the identified compounds.  
 
In general the toxicity decrease with the degradation of the main compound. The only 
compound that might be more toxic than diclofenac is D3, which is also the most detrimental for 
the green algae. 
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The least toxic compound for daphnid and fish is D6 which exceeds 600 mg/L. However, for 
green algae, the presence of D6 it could be damaging and for the seawater fish, it was not 
possible to estimate the toxicity.  
The most significant compound to determine the toxicity is D1 because is the most 
abundant at the end of the experimentation and is considerably detrimental regarding the 
others.  With direct photolysis, the final concentration of D1 is twice as the UV/H2O2 treatment 
(see figure 16).  This means that the presence of H2O2 decreases the toxicity of the sample, 
because can remove a large amount of the one of the most toxic degradation compounds. 
Figure 16. The final amount of the identified compounds after the degradation by UV and 
UV/H2O2. 
 
Looking at the degradation pathway (figure 14) it can be deduced that, as expected, the loss 
of chlorines entails the decrease of the toxicity. 
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5. CONCLUSIONS 
The conclusions deduced from the work carried out are the following: 
 Direct photolysis with UV and the combination of UV with hydrogen peroxide are 
effective methods for diclofenac removal. 
 The presence of hydrogen peroxide does not represent a significant improvement in 
the rate of diclofenac degradation. 
 The degradation process follows a pseudo-first-order kinetics. 
 Experiments done with only H2O2 or with solar light show a very low diclofenac 
removal. 
 Using liquid chromatography coupled to high-resolution mass spectrometry (LC-
HRMS), the transformation products were identified following the ruler based on 
accurate mass measurements, and a tentative degradation pathway was proposed. 
 The toxicity of the final products was estimated by ECOSAR and it was observed that 
the loss of chlorines during the degradation results in a decrease of the toxicity. 
 The use of hydrogen peroxide in the degradation process (UV/H2O2) implies a 
decrease in toxicity. 
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ACRONYMS 
AGC Automatic Gain Control 
AOPs Advanced Oxidation Processes 
ECOSAR Ecological Structure Activity Relationships 
EPA Environmental Protection Agency 
EQS Environmental quality standard 
ESI-MS Electrospray ionisation mass spectrometry 
FWHM Full Width of the peak at Half its Maximum 
HLB Hydrophilic-lipophilic balance 
IUPAC International Union of Pure and Applied Chemistry 
LC50 Lethal concentrations 
LC-HRMS Liquid chromatography coupled to high-resolution mass spectrometry 
NSAID Non-steroidal anti-inflammatory drug 
QSARs Quantitative Structure Activity Relationships 
RDB Ring Double Bond 
SPE solid phase extraction 
TIC Total ion current 
TOC Total organic carbon 
TOF Time-of-flight 
tR Retention time  
UV Ultraviolet  
UVC Ultraviolet C 
WFD Water Framework Directive 
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WL Watch List 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
